Total Payments
$11,502
2024 Payments
$3,491
Companies
23
Transactions
557
Medicare Patients
2,934
Medicare Billing
$198,890
Payment Breakdown by Category
Food & Beverage$11,057 (96.1%)
Education$444.98 (3.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,057 | 552 | 96.1% |
| Education | $444.98 | 5 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $2,092 | 130 | $0 (2024) |
| ABBVIE INC. | $2,055 | 117 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,118 | 25 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $809.02 | 48 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $669.78 | 22 | $0 (2024) |
| Amgen Inc. | $656.04 | 32 | $0 (2024) |
| GENZYME CORPORATION | $641.36 | 24 | $0 (2024) |
| UCB, Inc. | $592.58 | 16 | $0 (2024) |
| PFIZER INC. | $576.19 | 33 | $0 (2024) |
| Incyte Corporation | $553.13 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,491 | 159 | Janssen Biotech, Inc. ($445.42) |
| 2023 | $3,732 | 192 | ABBVIE INC. ($562.32) |
| 2022 | $3,796 | 190 | Janssen Biotech, Inc. ($1,052) |
| 2021 | $483.21 | 16 | NOVARTIS PHARMACEUTICALS CORPORATION ($136.09) |
All Payment Transactions
557 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $7.14 | General |
| 12/19/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Dermatology | ||||||
| 12/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Dermatology | ||||||
| 12/16/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $22.91 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $26.20 | General |
| 12/09/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $36.06 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $9.74 | General |
| Category: Inflammation & Immunology | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Dermatology | ||||||
| 11/26/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $8.56 | General |
| 11/19/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $8.76 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.71 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.22 | General |
| Category: Immunology | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.68 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $9.33 | General |
| Category: Dermatology | ||||||
| 11/07/2024 | PFIZER INC. | LITFULO (Drug) | Food and Beverage | In-kind items and services | $28.54 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $26.93 | General |
| Category: Immunology | ||||||
| 10/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Immunology | ||||||
| 10/11/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $29.89 | General |
| 10/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.99 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $4.84 | General |
| Category: Immunology | ||||||
| 10/09/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: Inflammation & Immunology | ||||||
| 10/08/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $39.96 | General |
| Category: Dermatology | ||||||
| 10/08/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Dermatology | ||||||
| 10/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.28 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 656 | 1,184 | $221,148 | $48,719 |
| 2021 | 13 | 1,262 | 2,123 | $202,069 | $87,354 |
| 2020 | 13 | 1,016 | 1,520 | $148,787 | $62,817 |
Total Patients
2,934
Total Services
4,827
Medicare Billing
$198,890
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 165 | 238 | $58,476 | $14,837 | 25.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 69 | 92 | $33,116 | $7,720 | 23.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 126 | 149 | $32,850 | $5,972 | 18.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 70 | 84 | $28,392 | $5,834 | 20.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 69 | 69 | $24,633 | $4,903 | 19.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 36 | 37 | $13,949 | $3,048 | 21.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 84 | 466 | $9,148 | $2,418 | 26.4% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 12 | 17 | $10,132 | $1,937 | 19.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $6,994 | $1,349 | 19.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 12 | 19 | $3,458 | $701.29 | 20.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 281 | 360 | $40,702 | $20,237 | 49.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 161 | 192 | $32,030 | $13,211 | 41.2% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 165 | 189 | $29,106 | $12,273 | 42.2% |
| 17000 | Destruction of skin growth | Office | 2021 | 188 | 227 | $23,311 | $7,995 | 34.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 101 | 101 | $16,895 | $6,723 | 39.8% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 41 | 64 | $11,108 | $4,973 | 44.8% |
| 12032 | Repair of wound (2.6 to 7.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs | Office | 2021 | 14 | 17 | $8,247 | $4,008 | 48.6% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 32 | 34 | $7,752 | $3,924 | 50.6% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 142 | 781 | $6,291 | $3,695 | 58.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 39 | 39 | $9,891 | $3,377 | 34.1% |
| 17262 | Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs | Office | 2021 | 25 | 29 | $8,036 | $3,272 | 40.7% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 56 | 73 | $6,049 | $2,913 | 48.2% |
| 69100 | Biopsy of ear | Office | 2021 | 17 | 17 | $2,651 | $753.08 | 28.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 236 | 284 | $41,822 | $16,544 | 39.6% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 140 | 159 | $22,055 | $9,853 | 44.7% |
About Kieu Dang, PAC
Kieu Dang, PAC is a Dermatology healthcare provider based in Bellevue, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437167327.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kieu Dang, PAC has received a total of $11,502 in payments from pharmaceutical and medical device companies, with $3,491 received in 2024. These payments were reported across 557 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($11,057).
As a Medicare-enrolled provider, Dang has provided services to 2,934 Medicare beneficiaries, totaling 4,827 services with total Medicare billing of $198,890. Data is available for 3 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Bellevue, WA
- Active Since 08/04/2006
- Last Updated 09/27/2021
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1437167327
Products in Payments
- TREMFYA (Drug) $1,469
- SKYRIZI (Biological) $1,311
- Sotyktu (Drug) $1,080
- DUPIXENT (Biological) $907.64
- Otezla (Drug) $656.04
- REMICADE (Biological) $622.82
- RINVOQ (Biological) $585.45
- OPZELURA (Drug) $553.13
- ILUMYA (Biological) $544.80
- COSENTYX (Drug) $453.05
- CIBINQO (Drug) $384.98
- VTAMA (Drug) $368.92
- COSENTYX (Biological) $274.68
- Cimzia (Drug) $272.35
- TALTZ (Drug) $218.93
- Zoryve (Drug) $193.11
- Bimzelx (Biological) $185.71
- HUMIRA (Biological) $143.70
- EUCRISA (Drug) $133.14
- Winlevi (Drug) $101.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Bellevue
Dr. Clive Liu, Md, MD
Dermatology — Payments: $3.0M
Dermatology $3.0M
Sharon Kelly, Md, MD
Dermatology — Payments: $140,377
Dermatology $140,377
Jing Liu, Md, MD
Dermatology — Payments: $38,377
Dermatology $38,377
Deetta Gray, M.d., Faad, Frcpc, M.D., FAAD, FRCPC
Dermatology — Payments: $11,798
Dermatology $11,798
Diane Chiu, Md, MD
Dermatology — Payments: $8,139
Dermatology $8,139
Dr. Amanda Norton, Dnp, Arnp, DNP, ARNP
Dermatology — Payments: $7,120
Dermatology $7,120